728
Views
17
CrossRef citations to date
0
Altmetric
Reviews

Polyamine biomarkers as indicators of human disease

, , , ORCID Icon, , & show all
Pages 77-94 | Received 16 Sep 2020, Accepted 06 Jan 2021, Published online: 25 Jan 2021

References

  • Aisen, P.S., Cummings, J., and Schneider, L.S., 2012. Symptomatic and nonamyloid/tau based pharmacologic treatment for Alzheimer disease. Cold spring harbor perspectives in medicine, 2 (3), a006395.
  • AlMoharib, H.S., et al., 2014. Oral fluid based biomarkers in periodontal disease: part 1. Saliva. Journal of international oral health, 6 (4), 95–103.
  • Ariyamuthu, V.K., Nolph, K.D., and Ringdahl, B.E., 2013. Periodontal disease in chronic kidney disease and end-stage renal disease patients: a review. Cardiorenal medicine, 3 (1), 71–78.
  • Asai, Y., et al., 2018. Elevated polyamines in saliva of pancreatic cancer. Cancers, 10 (2), 43.
  • Auvinen, M., et al., 1997. Human ornithine decarboxylase-overproducing NIH3T3 cells induce rapidly growing, highly vascularized tumors in nude mice. Cancer research, 57 (14), 3016–3025.
  • Babbar, N., Murray-Stewart, T., and Casero, R.A., 2007. Inflammation and polyamine catabolism: the good, the bad and the ugly. Biochemical society transactions, 35 (2), 300–304.
  • Banda, J., et al., 2020. Biomarkers for diagnosis and prediction of outcomes in contrast-induced nephropathy. International journal of nephrology, 2020, 1–11.
  • Barnes, V., et al., 2009. Acceleration of purine degradation by periodontal diseases. Journal of dental research, 88 (9), 851–855.
  • Barnes, V.M., et al., 2014. Global metabolomic analysis of human saliva and plasma from healthy and diabetic subjects, with and without periodontal disease. PLoS one, 9 (8), e105181.
  • Barros, S.P., et al., 2016. Gingival crevicular fluid as a source of biomarkers for periodontitis. Periodontology 2000, 70 (1), 53–64.
  • Battaglia, V., et al., 2014. Polyamine catabolism in carcinogenesis: potential targets for chemotherapy and chemoprevention. Amino acids, 46 (3), 511–519.
  • Berezow, A.B. and Darveau, R.P., 2011. Microbial shift and periodontitis. Periodontology 2000, 55 (1), 36–47.
  • Blennow, K., 2004. Cerebrospinal fluid protein biomarkers for Alzheimer’s disease. NeuroRx: the journal of the American Society for Experimental Neurotherapeutics, 1 (2), 213–225.
  • Blennow, K. and Zetterberg, H., 2018. Biomarkers for Alzheimer’s disease: current status and prospects for the future. Journal of internal medicine, 284 (6), 643–663.
  • Bosshardt, D.D., 2018. The periodontal pocket: pathogenesis, histopathology and consequences. Periodontology 2000, 76 (1), 43–50.
  • Bray, F., et al., 2018. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: a cancer journal for clinicians, 68 (6), 394–424.
  • Britschgi, M., et al., 2011. Modeling of pathological traits in Alzheimer’s disease based on systemic extracellular signaling proteome. Molecular & cellular proteomics, 10 (10), M111.008862.
  • Cañizares, F., et al., 1999. Prognostic value of ornithine decarboxylase and polyamines in human breast cancer: correlation with clinicopathologic parameters. Clin cancer res, 5 (8), 2035–2041.
  • Canto, M.I., et al., 2012. Frequent detection of pancreatic lesions in asymptomatic high-risk individuals. Gastroenterology, 142 (4), 796–804.
  • Casero, R.A., Murray Stewart, T., and Pegg, A.E., 2018. Polyamine metabolism and cancer: treatments, challenges and opportunities. Nature reviews. Cancer, 18 (11), 681–695.
  • Cekici, A., et al., 2014. Inflammatory and immune pathways in the pathogenesis of periodontal disease. Periodontology 2000, 64 (1), 57–80.
  • Chen, L., et al., 2018. Inflammatory responses and inflammation-associated diseases in organs. Oncotarget, 9 (6), 7204–7218.
  • Cho, M.I. and Garant, P.R., 2000. Development and general structure of the periodontium. Periodontology 2000, 24, 9–27.
  • Choong, M.K. and Tsafnat, G., 2012. The implications of biomarker evidence for systematic reviews. BMC medical research methodology, 12, 176.
  • Cipolla, B., et al., 1994. Erythrocyte polyamines and prognosis in stage D2 prostatic carcinoma patients. Journal of urology, 151 (3), 629–633.
  • Collinson, P.O., 2013. Evaluating new diagnostic and prognostic biomarkers in cardiovascular disease. Heart, 99 (11), 757–758.
  • Cornejo Ulloa, P., van der Veen, M.H., and Krom, B.P., 2019. Review: modulation of the oral microbiome by the host to promote ecological balance. Odontology, 107 (4), 437–448.
  • Correia-Neves, M., et al., 2019. Biomarkers for tuberculosis: the case for lipoarabinomannan. ERJ open research, 5 (1), 00115–2018.
  • Cummings, J., et al., 2018. Alzheimer’s disease drug development pipeline: 2018. Alzheimer’s & dementia, 4, 195–214.
  • Damiani, E. and Wallace, H.M., 2018. Polyamines and cancer. Methods in molecular biology, 1694, 469–488.
  • Darveau, R.P., et al., 2002. Porphyromonas gingivalis lipopolysaccharide is both agonist and antagonist for p38 mitogen-activated protein kinase activation. Infection and immunity, 70 (4), 1867–1873.
  • de Almeida, P.V., et al., 2008. Saliva composition and functions: a comprehensive review. The journal of contemporary dental practice, 9 (3), 72–80.
  • deHart, G.W., et al., 2008. The alpha9beta1 integrin enhances cell migration by polyamine-mediated modulation of an inward-rectifier potassium channel. Proceedings of the National Academy of Sciences of the United States of America, 105 (20), 7188–7193.,
  • de Pablo, P., et al., 2009. Periodontitis in systemic rheumatic diseases. Nature reviews. Rheumatology, 5 (4), 218–224.
  • Delanaye, P., et al., 2014. Calibration and precision of serum creatinine and plasma cystatin C measurement: impact on the estimation of glomerular filtration rate. Journal of nephrology, 27 (5), 467–475.
  • Deng, W., et al., 2008. Role of ornithine decarboxylase in breast cancer. Acta biochimica et biophysica sinica, 40 (3), 235–243.
  • Deo, P. and Deshmukh, R., 2019. Oral microbiome: unveiling the fundamentals. Journal of oral and maxillofacial pathology, 23 (1), 122–128.
  • Diamandis, E.P., 2012. The failure of protein cancer biomarkers to reach the clinic: why, and what can be done to address the problem? BMC medicine, 10 (1), 87–85.
  • Dodds, M., et al., 2015. Saliva A review of its role in maintaining oral health and preventing dental disease. BDJ team, 2 (1–8), 11–13.
  • Doecke, J.D., et al., 2012. Blood-based protein biomarkers for diagnosis of Alzheimer disease. Archives of neurology, 69 (10), 1318–1325.
  • Dye, B.A., et al., 2009. Serum antibodies to periodontal bacteria as diagnostic markers of periodontitis. Journal of periodontology, 80 (4), 634–647.
  • Erdman, S.H., et al., 1999. APC-dependent changes in expression of genes influencing polyamine metabolism, and consequences for gastrointestinal carcinogenesis, in the Min mouse. Carcinogenesis, 20 (9), 1709–1713.
  • Ferrara, N., 2004. Vascular endothelial growth factor as a target for anticancer therapy. The oncologist, 9 (S1), 2–10.
  • Ferri, C.P., et al., 2005. Global prevalence of dementia: a Delphi consensus study. Lancet, 366 (9503), 2112–2117.
  • Fine, D. and Mandel, I., 1986. Indicators of periodontal disease activity: an evaluation. Journal of clinical periodontology, 13 (5), 533–546.
  • Fogo, A.B., 2007. Mechanisms of progression of chronic kidney disease. Pediatric nephrology, 22 (12), 2011–2022.
  • Folch, J., et al., 2016. Current research therapeutic strategies for Alzheimer’s disease treatment. Neural plasticity, 2016, 8501693.
  • Fujita, T., et al., 2018. Regulation of defensive function on gingival epithelial cells can prevent periodontal disease. Japanese dental science review, 54 (2), 66–75.
  • Fung, E. and Kurella Tamura, M., 2016. Epidemiology and public health concerns of ckd in older adults. Advances in chronic kidney disease, 23 (1), 8–11.
  • Fusi, E., et al., 2008. Effects of putrescine, cadaverine, spermine, spermidine and β-phenylethylamine on cultured bovine mammary epithelial cells. Italian journal of animal science, 7 (2), 131–140.
  • Gadekar, N.B., et al., 2018. Detection of antibodies against aggregatibacter actinomycetemcomitans in serum and saliva through ELISA in periodontally healthy individuals and individuals with chronic periodontitis. Microbial pathogenesis, 125, 438–442.
  • Galimberti, D. and Scarpini, E., 2010. Treatment of Alzheimer’s disease: symptomatic and disease-modifying approaches. Current aging science, 3 (1), 46–56.
  • Gao, L., et al., 2018. Oral microbiomes: more and more importance in oral cavity and whole body. Protein & cell, 9 (5), 488–500.
  • Gerner, E.W. and Meyskens, F.L., 2004. Polyamines and cancer: old molecules, new understanding. Nature reviews. Cancer, 4 (10), 781–792.
  • Ghallab, N.A., 2018. Diagnostic potential and future directions of biomarkers in gingival crevicular fluid and saliva of periodontal diseases: review of the current evidence. Archives of oral biology, 87, 115–124.
  • Goek, O.N., et al., 2013. Metabolites associate with kidney function decline and incident chronic kidney disease in the general population. Nephrology, dialysis, transplantation, 28 (8), 2131–2138.
  • Goforth, J.B., Walter, N.E., and Karatan, E., 2013. Effects of polyamines on Vibrio cholerae virulence properties. PLoS one, 8 (4), e60765.
  • Goletti, D., et al., 2016. Tuberculosis biomarkers: from diagnosis to protection. Infectious disease reports, 8 (2), 6568.
  • Gomez, B., et al., 2019. Performance of blood biomarkers to rule out invasive bacterial infection in febrile infants under 21 days old. Archives of disease in childhood, 104 (6), 547–551.
  • Goossens, N., et al., 2015. Cancer biomarker discovery and validation. Translational cancer research, 4 (3), 256–269.
  • Grundke-Iqbal, I., et al., 1986. Abnormal phosphorylation of the microtubule-associated protein tau (tau) in Alzheimer cytoskeletal pathology. Proceedings of the National Academy of Sciences of the United States of America, 83 (13), 4913–4917.
  • Guerra, P.R., et al., 2018. Putrescine biosynthesis and export genes are essential for normal growth of avian pathogenic Escherichia coli. BMC microbiology, 18 (1), 226.
  • Hajishengallis, G., 2015. Periodontitis: from microbial immune subversion to systemic inflammation. Nature reviews. Immunology, 15 (1), 30–44.
  • Hajishengallis, G. and Lamont, R.J., 2012. Beyond the red complex and into more complexity: the polymicrobial synergy and dysbiosis (PSD) model of periodontal disease etiology. Molecular oral microbiology, 27 (6), 409–419.
  • Handa, A.K., Fatima, T., and Mattoo, A.K., 2018. Polyamines: bio-molecules with diverse functions in plant and human health and disease. Frontiers in chemistry, 6, 10.
  • Hernández, M., et al., 2011. Host-pathogen interactions in progressive chronic periodontitis. Journal of dental research, 90 (10), 1164–1170.
  • Hickey, N.A., et al., 2020. Exploring the putative interactions between chronic kidney disease and chronic periodontitis. Critical reviews in microbiology, 46 (1), 61–77.
  • Hienz, S.A., Paliwal, S., and Ivanovski, S., 2015. Mechanisms of bone resorption in periodontitis. Journal of immunology research, 2015, 615486.
  • Higgins, M.L., et al., 1969. The effect of polyamines on cell culture cells. Journal of cellular physiology, 74 (2), 149–154.
  • Hill, J., et al., 2014. Pathogenic microbes, the microbiome, and Alzheimer’s disease (AD). Frontiers in aging neuroscience, 6, 127–132.
  • Hu, W.T., et al., 2012. Plasma multianalyte profiling in mild cognitive impairment and Alzheimer disease. Neurology, 79 (9), 897–905.
  • Humphrey, S.P. and Williamson, R.T., 2001. A review of saliva: normal composition, flow, and function. Journal of prosthetic dentistry, 85 (2), 162–169.
  • Hwang, H., Hwang, B.Y., and Bueno, J., 2018. Biomarkers in infectious diseases. Disease markers, 2018, 8509127.
  • Ide, M., et al., 2016. Periodontitis and cognitive decline in Alzheimer’s disease. PLoS one, 11 (3), e0151081.
  • Igarashi, K. and Kashiwagi, K., 2000. Polyamines: mysterious modulators of cellular functions. Biochemical and biophysical research communications, 271 (3), 559–564.
  • Igarashi, K., et al., 2006. Polyamines in renal failure. Amino acids, 31 (4), 477–483.
  • Ilic, M. and Ilic, I., 2016. Epidemiology of pancreatic cancer. World journal of gastroenterology, 22 (44), 9694–9705.
  • Iqbal, K., et al., 2000. Mechanism of neurofibrillary degeneration and pharmacologic therapeutic approach. Journal of neural transmission. Supplementum, 59, 213–222.
  • Jelsbak, L., et al., 2012. Polyamines are required for virulence in Salmonella enterica serovar typhimurium. PLoS one, 7 (4), e36149.
  • Jun, J.Y., et al., 2007. Effects of polyamine depletion by alpha-difluoromethylornithine on in vitro and in vivo biological properties of 4T1 murine mammary cancer cells. Breast cancer research and treatment, 105 (1), 29–36.
  • Kamer, A.R., et al., 2015. Periodontal disease associates with higher brain amyloid load in normal elderly. Neurobiology of aging, 36 (2), 627–633.
  • Kamio, Y., 1987. Structural specificity of diamines covalently linked to peptidoglycan for cell growth of Veillonella alcalescens and Selenomonas ruminantium. Journal of bacteriology, 169 (10), 4837–4840.
  • Kang, I.H., et al., 2007. Cadaverine protects Vibrio vulnificus from superoxide stress. Journal of microbiology and biotechnology, 17 (1), 176–179.
  • Keesman, M., et al., 2016. Consumption simulations induce salivation to food cues. PLoS one, 11 (11), e0165449.
  • Kesavalu, L., et al., 2007. Rat model of polymicrobial infection, immunity, and alveolar bone resorption in periodontal disease. Infection and immunity, 75 (4), 1704–1712.
  • Khan, Z. and Pandey, M., 2014. Role of kidney biomarkers of chronic kidney disease: an update. Saudi journal of biological sciences, 21 (4), 294–299.
  • Khuhawar, M.Y. and Qureshi, G.A., 2001. Polyamines as cancer markers: applicable separation methods. Journal of chromatography B: biomedical sciences and applications, 764 (1–2), 385–407.
  • Khurshid, Z., et al., 2017. Human gingival crevicular fluids (GCF) proteomics: an overview. Dentistry journal, 5 (1), 12.
  • Kilian, M., et al., 2016. The oral microbiome - an update for oral healthcare professionals. British dental journal, 221 (10), 657–666.
  • Kitazawa, M., et al., 2005. Lipopolysaccharide-induced inflammation exacerbates tau pathology by a cyclin-dependent kinase 5-mediated pathway in a transgenic model of Alzheimer’s disease. The journal of neuroscience, 25 (39), 8843–8853.
  • Kuboniwa, M., et al., 2016. Prediction of periodontal inflammation via metabolic profiling of saliva. Journal of dental research, 95 (12), 1381–1386.
  • Kubota, S., et al., 1997. Ornithine decarboxylase overexpression in mouse 10T1/2 fibroblasts: cellular transformation and invasion. Journal of the national cancer institute, 89 (8), 567–571.
  • Kulic, L. and Unschuld, P.G., 2016. Recent advances in cerebrospinal fluid biomarkers for the detection of preclinical Alzheimer’s disease. Current opinion in neurology, 29 (6), 749–755.
  • Kuramitsu, H.K., et al., 2007. Interspecies interactions within oral microbial communities. Microbiology and molecular biology reviews, 71 (4), 653–670.
  • Kurihara, S., et al., 2005. A novel putrescine utilization pathway involves gamma-glutamylated intermediates of Escherichia coli K-12. The journal of biological chemistry, 280 (6), 4602–4608.
  • Kusano, T., et al., 2008. Polyamines: essential factors for growth and survival. Planta, 228 (3), 367–381.
  • Kushner, D., et al., 1991. Polyamines in the anemia of end-stage renal disease. Kidney international, 39 (4), 725–732.
  • Lamont, R.J. and Hajishengallis, G., 2015. Polymicrobial synergy and dysbiosis in inflammatory disease. Trends in molecular medicine, 21 (3), 172–183.
  • Lamster, I.B., 1997. Evaluation of components of gingival crevicular fluid as diagnostic tests. Annals of periodontology, 2 (1), 123–137.
  • Lamster, I.B. and Ahlo, J.K., 2007. Analysis of gingival crevicular fluid as applied to the diagnosis of oral and systemic diseases. Annals of the New York Academy of Sciences, 1098, 216–229.
  • Lamster, I.B., et al., 1987. The polyamines putrescine, spermidine and spermine in human gingival crevicular fluid. Archives of oral biology, 32 (5), 329–333.
  • Laugisch, O., et al., 2018. Periodontal pathogens and associated intrathecal antibodies in early stages of Alzheimer’s disease. Journal of Alzheimer’s disease, 66 (1), 105–114.
  • Lertpimonchai, A., et al., 2019. Periodontitis as the risk factor of chronic kidney disease: mediation analysis. Journal of clinical periodontology, 46 (6), 631–639.
  • Levey, A.S., 1990. Measurement of renal function in chronic renal disease. Kidney international, 38 (1), 167–184.
  • Levey, A.S., Inker, L.A., and Coresh, J., 2014. GFR estimation: from physiology to public health. American journal of kidney diseases, 63 (5), 820–834.
  • Lindahl, A., et al., 2017. Discrimination of pancreatic cancer and pancreatitis by LC-MS metabolomics. Metabolomics, 13 (5), 61.
  • Lohinai, Z., et al., 2012. Bacterial lysine decarboxylase influences human dental biofilm lysine content, biofilm accumulation, and subclinical gingival inflammation. Journal of periodontology, 83 (8), 1048–1056.
  • Long, J., et al., 2016. Discovery of novel biomarkers for Alzheimer’s disease from blood. Disease markers, 2016, 4250480.
  • López, N.J., 2000. Occurrence of Actinobacillus actinomycetemcomitans, Porphyromonas gingivalis, and Prevotella intermedia in progressive adult periodontitis. Journal of periodontology, 71 (6), 948–954.
  • Lopez-Giacoman, S. and Madero, M., 2015. Biomarkers in chronic kidney disease, from kidney function to kidney damage. World journal of nephrology, 4 (1), 57–73.
  • Lowry, L.K., 1995. Role of biomarkers of exposure in the assessment of health risks. Toxicology letters, 77 (1–3), 31–38.
  • Lubell, Y. and Althaus, T., 2017. Biomarker tests for bacterial infection-a costly wait for the holy grail. The lancet. Infectious diseases, 17 (4), 369–370.
  • Lynge Pedersen, A.M. and Belstrøm, D., 2019. The role of natural salivary defences in maintaining a healthy oral microbiota. Journal of dentistry, 80, 3–12.
  • Macdougall, I.C., 2001. Role of uremic toxins in exacerbating anemia in renal failure. Kidney international, 59 (s78), 67–72.
  • Mandal, S., et al., 2013. Depletion of cellular polyamines, spermidine and spermine, causes a total arrest in translation and growth in mammalian cells. Proceedings of the National Academy of Sciences of the United States of America, 110 (6), 2169–2174.
  • Mariggiò, M.A., et al., 2004. In vitro effects of polyamines on polymorphonuclear cell apoptosis and implications in the pathogenesis of periodontal disease. Immunopharmacology and immunotoxicology, 26 (1), 93–101.
  • Marsh, P.D., 2000. Role of the oral microflora in health. Microbial ecology in health and disease, 12 (3), 130–137.
  • Marsh, P.D., 2003. Are dental diseases examples of ecological catastrophes? Microbiology, 149 (2), 279–294.
  • Mason, S. and Joyce, J., 2011. Proteolytic networks in cancer. Trends in cell biology, 21 (4), 228–237.
  • Mayerle, J., et al., 2018. Metabolic biomarker signature to differentiate pancreatic ductal adenocarcinoma from chronic pancreatitis. Gut, 67 (1), 128–137.
  • Mayeux, R., 2004. Biomarkers: potential uses and limitations. NeuroRx: the journal of the American Society for Experimental Neurotherapeutics, 1 (2), 182–188.
  • McGhee, D.J., et al., 2014. A systematic review of biomarkers for disease progression in Alzheimer’s disease. PLoS one, 9 (2), e88854.
  • Miller-Fleming, L., et al., 2015. Remaining mysteries of molecular biology: the role of polyamines in the cell. Journal of molecular biology, 427 (21), 3389–3406.
  • Minois, N., Carmona-Gutierrez, D., and Madeo, F., 2011. Polyamines in aging and disease. Aging, 3 (8), 716–732.
  • Murray-Stewart, T.R., Woster, P.M., and Casero, R.A., 2016. Targeting polyamine metabolism for cancer therapy and prevention. Biochemical journal, 473 (19), 2937–2953.
  • Nair, M., Sandhu, S.S., and Sharma, A.K., 2018. Cancer molecular markers: a guide to cancer detection and management. Seminars in cancer biology, 52 (1), 39–55.
  • Nair, S., Faizuddin, M., and Dharmapalan, J., 2014. Role of autoimmune responses in periodontal disease. Autoimmune diseases, 2014, 596824.
  • Nakajima, T., et al., 2018. Urinary polyamine biomarker panels with machine-learning differentiated colorectal cancers, benign disease, and healthy controls. International journal of molecular sciences., 19 (3), 29518931.
  • Nakamya, M.F., et al., 2018. The role of cadaverine synthesis on pneumococcal capsule and protein expression. Medical sciences, 6 (1), 8.
  • Nasrallah, G.K., et al., 2011. Legionella pneumophila requires polyamines for optimal intracellular growth. Journal of bacteriology, 193 (17), 4346–4360.
  • Nazar Majeed, Z., et al., 2016. Identification of gingival crevicular fluid sampling, analytical methods, and oral biomarkers for the diagnosis and monitoring of periodontal diseases: a systematic review. Disease markers, 2016, 1804727.
  • Nazir, M.A., 2017. Prevalence of periodontal disease, its association with systemic diseases and prevention. International journal of health sciences, 11 (2), 72–80.
  • Nędzi-Góra, M., Kowalski, J., and Górska, R., 2017. The immune response in periodontal tissues. Archivum immunologiae et therapiae experimentalis, 65 (5), 421–429.
  • Nelson, L. and Tabet, N., 2015. Slowing the progression of Alzheimer’s disease; what works? Ageing research reviews, 23 (B), 193–209.
  • Neyraud, E., Prinz, J., and Dransfield, E., 2003. NaCl and sugar release, salivation and taste during mastication of salted chewing gum. Physiology & behavior, 79 (4–5), 731–737.
  • Niemantsverdriet, E., et al., 2017. Alzheimer’s disease CSF biomarkers: clinical indications and rational use. Acta neurologica belgica, 117 (3), 591–602.
  • Nishihara, T. and Koseki, T., 2004. Microbial etiology of periodontitis. Periodontology 2000, 36, 14–26.
  • Nowotarski, S.L., Woster, P.M., and Casero, R.A., 2013. Polyamines and cancer: implications for chemotherapy and chemoprevention. Expert reviews in molecular medicine, 15, 23432972.
  • O’Bryant, S.E., et al., 2011. A blood-based screening tool for Alzheimer’s disease that spans serum and plasma: findings from TARC and ADNI. PLoS one, 6 (12), e28092.
  • Ozeki, M., et al., 2016. Metabolomic analysis of gingival crevicular fluid using gas chromatography/mass spectrometry. Mass spectrometry, 5 (1), A0047.
  • Panza, F., et al., 2019. Are antibodies directed against amyloid-β (Aβ) oligomers the last call for the Aβ hypothesis of Alzheimer’s disease? Immunotherapy, 11 (1), 3–6.
  • Park, M.H. and Igarashi, K., 2013. Polyamines and their metabolites as diagnostic markers of human diseases. Biomolecules & therapeutics, 21 (1), 1–9.
  • Patil, P.B. and Patil, B.R., 2011. Saliva: a diagnostic biomarker of periodontal diseases. Journal of Indian Society of Periodontology, 15 (4), 310–317.
  • Patil, S., et al., 2013. Microbial flora in oral diseases. The journal of contemporary dental practice, 14 (6), 1202–1208.
  • Pedersen, A.M., et al., 2002. Saliva and gastrointestinal functions of taste, mastication, swallowing and digestion. Oral diseases, 8 (3), 117–129.
  • Pegg, A.E., 2016. Functions of polyamines in mammals. The journal of biological chemistry, 291 (29), 14904–14912.
  • Piccolli, A.P., Nascimento, M.M.D., and Riella, M.C., 2017. Prevalence of chronic kidney disease in a population in southern Brazil. Brazilian journal of nephrology, 39 (4), 384–390.
  • Plombas, M., et al., 2002. Isotypic antibody response to plaque anaerobes in periodontal disease. Journal of periodontology, 73 (12), 1507–1511.
  • Poole, S., et al., 2013. Determining the presence of periodontopathic virulence factors in short-term postmortem Alzheimer’s disease brain tissue. Journal of Alzheimer’s disease, 36 (4), 665–677.
  • Preshaw, P.M., 2015. Detection and diagnosis of periodontal conditions amenable to prevention. BMC oral health, 15 (S1), 5.
  • Qiu, X., et al., 2017. The diagnostic value of serum creatinine and cystatin c in evaluating glomerular filtration rate in patients with chronic kidney disease: a systematic literature review and meta-analysis. Oncotarget, 8 (42), 72985–72999.
  • Ray, S., et al., 2007. Classification and prediction of clinical Alzheimer’s diagnosis based on plasma signaling proteins. Nature medicine, 13 (11), 1359–1362.
  • Ruggenenti, P., et al., 2012. Measuring and estimating GFR and treatment effect in ADPKD patients: results and implications of a longitudinal cohort study. PLoS one, 7 (2), e2533.
  • Russell, D.H., 1977. Clinical relevance of polyamines as biochemical markers of tumor kinetics. Clinical chemistry, 23 (1), 22–27.
  • Russell, D. and Snyder, S.H., 1968. Amine synthesis in rapidly growing tissues: ornithine decarboxylase activity in regenerating rat liver, chick embryo, and various tumors. Proceedings of the National Academy of Sciences of the United States of America, 60 (4), 1420–1427.
  • Rysz, J., et al., 2017. Novel biomarkers in the diagnosis of chronic kidney disease and the prediction of its outcome. International journal of molecular sciences, 18 (8), 28777303.
  • Saito, A., et al., 1983. Serum levels of polyamines in patients with chronic renal failure. Kidney international supplements, 16, 234–237.
  • Sakanaka, A., et al., 2017. Distinct signatures of dental plaque metabolic byproducts dictated by periodontal inflammatory status. Scientific reports, 7 (2), 42818.
  • Sarapur, S. and Shilpashree, H.S., 2012. Salivary pacemakers: a review. Dental research journal, 9, 20–25.
  • Sauter, E.R., 2017. Reliable biomarkers to identify new and recurrent cancer. European journal of breast health, 13 (4), 162–167.
  • Schatzle, M., et al., 2004. The clinical course of chronic periodontitis. Journal of clinical periodontology, 31 (12), 1122–1127.
  • Selleck, M.J., Senthil, M., and Wall, N.R., 2017. Making meaningful clinical use of biomarkers. Biomark insights, 12, 28659713.
  • Serrano-Pozo, A., et al., 2011. Neuropathological alterations in Alzheimer disease. Cold Spring Harbor Perspectives in Medicine, 1 (1), a006189.
  • Shah, P. and Swiatlo, E., 2008. A multifaceted role for polyamines in bacterial pathogens. Molecular microbiology, 68 (1), 4–16.
  • Shaikh, H.F.M., et al., 2018. Polymicrobial synergy and dysbiosis: an overview. Journal of Indian Society of Periodontology, 22 (2), 101–106.
  • Sharma, N. and Singh, A.N., 2016. Exploring biomarkers for Alzheimer’s disease. Journal of clinical and diagnostic research, 10 (7), 1–6.
  • Sindhu, K.K., 2016. Uremic toxins: some thoughts on acrolein and spermine. Renal failure, 38 (10), 1755–1758.
  • Singhrao, S.K., et al., 2015. Porphyromonas gingivalis periodontal infection and its putative links with Alzheimer’s disease. Mediators of inflammation, 2015, 137357.
  • Socransky, S.S., et al., 1998. Microbial complexes in subgingival plaque. Journal of clinical periodontology, 25 (2), 134–144.
  • Soda, K., 2011. The mechanisms by which polyamines accelerate tumor spread. Journal of experimental & clinical cancer research, 30, 95.
  • Srivastava, N., Nayak, P.A., and Rana, S., 2017. Point of care- a novel approach to periodontal diagnosis-a review. Journal of clinical and diagnostic research, 11, 1–6.
  • Stathopoulou, P.G., Buduneli, N., and Kinane, D.F., 2015. Systemic biomarkers for periodontitis. Current oral health reports, 2 (4), 218–226.
  • Stoothoff, W.H. and Johnson, G.V., 2005. Tau phosphorylation: physiological and pathological consequences. Biochimica et biophysica acta, 1739 (2–3), 280–297.
  • Strimbu, K. and Tavel, J.A., 2010. What are biomarkers? Current opinion in HIV and aids, 5 (6), 463–466.
  • Subbarao, K.C., et al., 2019. Gingival crevicular fluid: an overview. Journal of pharmacy and bioallied sciences, 11 (6), 135–139.
  • Sun, W.Y., et al., 2017. Evaluation of the expression of amine oxidase proteins in breast cancer. International journal of molecular sciences, 18 (12), 29261141.
  • Suzuki, N., Yoneda, M., and Hirofuji, T., 2013. Mixed red-complex bacterial infection in periodontitis. International journal of dentistry, 2013, 587279.
  • Taba, M., et al., 2005. Diagnostic biomarkers for oral and periodontal diseases. Dental clinics of North America, 49 (3), 551–571.
  • Tábi, T., et al., 2008. CE–LIF determination of salivary cadaverine and lysine concentration ratio as an indicator of lysine decarboxylase enzyme activity. Analytical and bioanalytical chemistry, 391 (2), 647–651.
  • Takahashi, T. and Kakehi, J., 2010. Polyamines: ubiquitous polycations with unique roles in growth and stress responses. Annals of botany, 105 (1), 1–6.
  • Takahashi, K., et al., 1997. IgG and IgA subclass mRNA-bearing plasma cells in periodontitis gingival tissue and immunoglobulin levels in the gingival crevicular fluid. Clinical & experimental immunology, 107 (1), 158–165.
  • Tang, B.M., et al., 2017. A novel immune biomarker. European respiratory journal, 49 (6), 1602098.
  • Tarnanas, I., et al., 2015. Five-year biomarker progression variability for Alzheimer’s disease dementia prediction: can a complex instrumental activities of daily living marker fill in the gaps? Alzheimer’s & dementia, 1 (4), 521–532.
  • Taylor, J.J. and Preshaw, P.M., 2016. Gingival crevicular fluid and saliva. Periodontology 2000, 70 (1), 7–10.
  • Thalhauser, C.J. and Komarova, N.L., 2012. Alzheimer’s disease: rapid and slow progression. Journal of the royal society, interface, 9 (66), 119–126.
  • Thoden van Velzen, S.K., Abraham-Inpijn, L., and Moorer, W.R., 1984. Plaque and systemic disease: a reappraisal of the focal infection concept. Journal of clinical periodontology, 11 (4), 209–220.
  • Thomas, R., Kanso, A., and Sedor, J., 2008. Chronic kidney disease and its complications. Primary care, 35 (2), 329–344.
  • Thyagarajan, B., et al., 2016. Analytical and biological variability in biomarker measurement in the hispanic community health study/study of latinos. Clinica chimica acta; international journal of clinical chemistry, 463, 129–137.
  • Tofalo, R., Cocchi, S., and Suzzi, G., 2019. Polyamines and gut microbiota. Frontiers in nutrition, 6, 16.
  • Torre, L.A., et al., 2017. Global cancer in women: burden and trends. Cancer epidemiology, biomarkers & prevention, 26 (4), 444–457.
  • Tsuchida, S., et al., 2017. Ubiquitination in periodontal disease: a review. International journal of molecular sciences, 18 (7), 28698506.
  • Tuttle, K., et al., 2019. Clinical characteristics of and risk factors for chronic kidney disease among adults and children. JAMA network open, 2 (12), e1918169.
  • Uehara, N., et al., 1980. Elevated contents of spermidine and spermine in the erythrocytes of cancer patients. Cancer, 45 (1), 108–111.
  • Urdea, M.S., et al., 2011. Saliva, diagnostics, and dentistry. Advances in dental research, 23 (4), 353–359.
  • Viau, A., et al., 2010. Lipocalin 2 is essential for chronic kidney disease progression in mice and humans. The journal of clinical investigation, 120 (11), 4065–4076.
  • Vinogradov, E. and Perry, M.B., 2000. Structural analysis of the core region of lipopolysaccharides from Proteus mirabilis serotypes O6, O48 and O57. European journal of biochemistry, 267 (8), 2439–2446.
  • Vlachostergios, P.J. and Faltas, B.M., 2019. The molecular limitations of biomarker research in bladder cancer. World journal of urology, 37 (5), 837–848.
  • Wahid, A., et al., 2013. Bidirectional relationship between chronic kidney disease & periodontal disease. Pakistan journal of medical sciences, 29 (1), 211–215.
  • Wallis, R.S., et al., 2010. Biomarkers and diagnostics for tuberculosis: progress, needs, and translation into practice. Lancet, 375 (9729), 1920–1937.
  • Walters, J., 1987. Polyamine analysis of human gingival crevicular fluid. Journal of periodontal research, 22 (6), 522–523.
  • Wang, G.P., 2015. Defining functional signatures of dysbiosis in periodontitis progression. Genome medicine, 7 (1), 40.
  • White, M.T. and Xie, S.X., 2013. Adjustment for measurement error in evaluating diagnostic biomarkers by using an internal reliability sample. Statistics in medicine, 32 (27), 4709–4725.
  • Xu, X. and Veenstra, T.D., 2008. Analysis of biofluids for biomarker research. Proteomics. Clinical applications, 2 (10–11), 1403–1412.
  • Yeh, C.Y., et al., 2017. Assessing biological and technological variability in protein levels measured in pre-diagnostic plasma samples of women with breast cancer. Biomarker research, 5 (1), 30.
  • Yiannopoulou, K.G. and Papageorgiou, S.G., 2013. Current and future treatments for Alzheimer’s disease. Therapeutic advances in neurological disorders, 6 (1), 19–33.
  • Yven, C., et al., 2006. Impaired mastication modifies the dynamics of bolus formation. European journal of oral sciences, 114 (3), 184–190.
  • Zahedi, K., Barone, S., and Soleimani, M., 2019. Polyamine catabolism in acute kidney injury. International journal of molecular sciences, 20 (19), 31561575.
  • Zahedi, K., et al., 2003. Expression of SSAT, a novel biomarker of tubular cell damage, increases in kidney ischemia-reperfusion injury. American journal of physiology-renal physiology, 284 (5), 1046–1055.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.